NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $100,896 | -18.2% | 175,411 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $123,296 | +84.0% | 175,411 | +735.3% | 0.00% | +100.0% |
| Q3 2022 | $67,000 | -87.2% | 21,000 | -84.8% | 0.00% | -85.7% |
| Q2 2022 | $525,000 | -90.8% | 138,043 | -86.9% | 0.01% | -89.9% |
| Q1 2022 | $5,698,000 | +342.7% | 1,057,400 | +1011.7% | 0.07% | +392.9% |
| Q4 2021 | $1,287,000 | -26.9% | 95,116 | -2.9% | 0.01% | -30.0% |
| Q3 2021 | $1,760,000 | -24.5% | 98,000 | -27.9% | 0.02% | -35.5% |
| Q2 2021 | $2,330,000 | +94.2% | 135,865 | +126.4% | 0.03% | +19.2% |
| Q1 2021 | $1,200,000 | +81.3% | 60,000 | +50.0% | 0.03% | +62.5% |
| Q3 2020 | $662,000 | -64.3% | 40,010 | -50.0% | 0.02% | -74.2% |
| Q2 2020 | $1,854,000 | +57.7% | 80,000 | +21.2% | 0.06% | -6.1% |
| Q1 2020 | $1,176,000 | -31.9% | 66,000 | -17.5% | 0.07% | +13.8% |
| Q4 2019 | $1,728,000 | +136.7% | 80,000 | +100.0% | 0.06% | +52.6% |
| Q3 2019 | $730,000 | +113.5% | 40,000 | +471.4% | 0.04% | +46.2% |
| Q2 2018 | $342,000 | – | 7,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |